These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7930391)

  • 1. Type II pseudohypoaldosteronism. Report of a case and review of the literature.
    Muhammad S; Mamish ZM; Tucci JR
    J Endocrinol Invest; 1994 Jun; 17(6):453-7. PubMed ID: 7930391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?].
    Ader JL; Waeber B; Suc JM; Brunner HR; Tran-Van T; Durand D; Praddaude F
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():193-7. PubMed ID: 2973296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
    Schweiger B; Moriarty MW; Cadnapaphornchai MA
    Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II.
    Erdoğan G; Corapçioğlu D; Erdoğan MF; Hallioğlu J; Uysal AR
    J Endocrinol Invest; 1997 Dec; 20(11):681-4. PubMed ID: 9492109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary hypoaldosteronism and secondary pseudo-hypoaldosteronism].
    Klaus D; Lederle RM; Vecsei P
    Klin Wochenschr; 1984 Aug; 62(16):753-8. PubMed ID: 6090761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudohypoaldosteronism with normal blood pressure.
    Shoker A; Morris G; Skomro R; Laxdal V
    Clin Nephrol; 1996 Aug; 46(2):105-11. PubMed ID: 8869787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of varying potassium intake on atrial natriuretic hormone-induced suppression of aldosterone.
    Clinkingbeard C; Lawrence D; Shenker Y
    Am J Hypertens; 1991 May; 4(5 Pt 1):456-9. PubMed ID: 1829901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic hormone effect on renal function and aldosterone secretion in sodium depletion.
    Shenker Y
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R867-73. PubMed ID: 2974252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and hyperkalaemia responding to bendrofluazide.
    Lee MR; Ball SG; Thomas TH; Morgan DB
    Q J Med; 1979 Apr; 48(190):245-58. PubMed ID: 504550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome): is there increased proximal sodium reabsorption?
    Klemm SA; Gordon RD; Tunny TJ; Thompson RE
    Clin Invest Med; 1991 Dec; 14(6):551-8. PubMed ID: 1838973
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Mehandru SK; Haroon A; Masud A; Shah J; Kaur S; Masud A; Hossain A; Asif A; Vachharajani TJ
    Saudi J Kidney Dis Transpl; 2020; 31(5):1134-1139. PubMed ID: 33229781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary hypoaldosteronism, pseudo-hypoaldosteronism and distal tubular acidosis].
    Klaus D
    Klin Wochenschr; 1984 Aug; 62(16):747-52. PubMed ID: 6384650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
    Schambelan M; Sebastian A; Rector FC
    Kidney Int; 1981 May; 19(5):716-27. PubMed ID: 7026872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of mineralocorticoid-resistant renal hyperkalemia without sodium wasting (type II pseudohypoaldosteronism)].
    Ito K; Yamada K; Hasunuma K; Shiina T; Ebata T; Kikuno K; Yoshida S; Tamura Y; Yoshida S
    Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):425-9. PubMed ID: 3042897
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient pseudo-hypoaldosteronism following resection of the ileum: normal level of lymphocytic aldosterone receptors outside the acute phase.
    Vantyghem MC; Hober C; Evrard A; Ghulam A; Lescut D; Racadot A; Triboulet JP; Armanini D; Lefebvre J
    J Endocrinol Invest; 1999 Feb; 22(2):122-7. PubMed ID: 10195379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familiar hyperkalaemic acidosis.
    Licht JH; Amundson D; Hsueh WA; Lombardo JV
    Q J Med; 1985 Feb; 54(214):161-76. PubMed ID: 3885297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypoaldosteronism: report of a case presenting as failure to thrive.
    Buzi F; Bezante T; Brunori A; Notarangelo LD; Ugazio AG
    J Pediatr Endocrinol Metab; 1995; 8(1):61-5. PubMed ID: 7584700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High aldosterone and cortisol levels in salt wasting congenital adrenal hyperplasia: a clinical conundrum.
    Boddu SK; Madhavan S
    J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1327-1331. PubMed ID: 29127765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid-induced kaliuresis in type-II pseudohypoaldosteronism.
    Travis PS; Cushner HM
    Am J Med Sci; 1986 Oct; 292(4):235-40. PubMed ID: 3529961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-aldosterone in elderly patients with hyperkalaemia under anaesthesia.
    Kudoh A; Sakai T; Ishihara H; Matsuki A
    Eur J Anaesthesiol; 1999 Apr; 16(4):231-5. PubMed ID: 10234492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.